| Metric | FY 2017 | Prior Q | FY 2016 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $4.0B | — | $3.1B | — | 26.8% |
| Op. Income | $890M | — | $590M | — | 50.9% |
| Gross Margin | 27.4% | — | 23.5% | — | 3.9pp |
| Net Margin | 16.5% | — | 10.9% | — | 5.5pp |
| EPS (Diluted) | $1.36 | — | $0.74 | — | 84.2% |
| Free Cash Flow | -$238M | — | -$488M | — | 51.2% |
| Item | Amount |
|---|---|
| REVENUE | $4.0B |
| Cost of Revenue | $2.9B |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $172M |
| SG&A Expenses | $172M |
| Other Expenses | -$10M |
| Operating Expenses | $193M |
| Cost & Expenses | $3.1B |
| OPERATING INCOME | $890M |
| Interest Income | $0 |
| Interest Expense | $134M |
| Other Income/Expenses | -$135M |
| INCOME BEFORE TAX | $755M |
| Income Tax Expense | $104M |
| NET INCOME | $651M |
| D&A | $288M |
| EBIT | $818M |
| EBITDA | $1.2B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $4.0B |
| Cost of Revenue | $2.9B |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $172M |
| SG&A Expenses | $172M |
| Other Expenses | -$10M |
| Operating Expenses | $193M |
| Cost & Expenses | $3.1B |
| OPERATING INCOME | $890M |
| Interest Income | $0 |
| Interest Expense | $134M |
| Other Income/Expenses | -$135M |
| INCOME BEFORE TAX | $755M |
| Income Tax Expense | $104M |
| NET INCOME | $651M |
| D&A | $288M |
| EBIT | $818M |
| EBITDA | $1.2B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $651M |
| Depreciation & Amortization | $279M |
| Stock-Based Compensation | $53M |
| Deferred Income Tax | $104M |
| Other Non-Cash Items | $31M |
| Change in Working Capital | -$13M |
| OPERATING CASH FLOW | $1.1B |
| Capital Expenditure | -$1.3B |
| Acquisitions (Net) | -$983M |
| Purchases of Investments | -$5M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$108M |
| NET CASH FROM INVESTING | -$2.4B |
| Net Debt Issuance | $1.8B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$571M |
| Other Financing Activities | $17M |
| NET CASH FROM FINANCING | $1.5B |
| FREE CASH FLOW | -$238M |
| Net Change in Cash | $209M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $235M |
| Short-Term Investments | $0 |
| Net Receivables | $374M |
| Inventory | $123M |
| Other Current Assets | $3M |
| TOTAL CURRENT ASSETS | $747M |
| PP&E (Net) | $9.9B |
| Goodwill | $2.8B |
| Intangible Assets | $616M |
| Long-Term Investments | $4.6B |
| Tax Assets | $31M |
| Other Non-Current Assets | $10M |
| TOTAL NON-CURRENT ASSETS | $17.9B |
| TOTAL ASSETS | $18.7B |
| Account Payables | $340M |
| Short-Term Debt | $187M |
| Deferred Revenue | $250M |
| Other Current Liabilities | $279M |
| TOTAL CURRENT LIABILITIES | $835M |
| Long-Term Debt | $5.3B |
| Deferred Revenue NC | $99M |
| Deferred Tax Liabilities | $1.7B |
| Other Non-Current Liabilities | $551M |
| TOTAL NON-CURRENT LIABILITIES | $7.7B |
| TOTAL LIABILITIES | $8.6B |
| Common Stock | $9.8B |
| Additional Paid-In Capital | $9.8B |
| Retained Earnings | -$1.5B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$5M |
| Other Equity | -$9.8B |
| TOTAL STOCKHOLDERS' EQUITY | $10.1B |
| Minority Interest | $44M |
| TOTAL EQUITY | $10.1B |
| TOTAL LIABILITIES & EQUITY | $18.7B |
| Total Debt | $5.5B |
| Net Debt | $5.3B |